Krystal Biotech Inc. (KRYS)
NASDAQ · Healthcare
Krystal Biotech Inc. EPS 2020–2025
Krystal Biotech Inc. annual/quarterly eps history and growth rate from 2020 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Krystal Biotech Inc. eps for the quarter ending March 31, 2026 was $1.83, a 52.50% increase year-over-year.
- Krystal Biotech Inc. annual eps for 2025 was $6.84, a 128.00% increase from 2024.
- Krystal Biotech Inc. annual eps for 2024 was $3.00, a 669.23% increase from 2023.
- Krystal Biotech Inc. annual eps for 2023 was $0.39, a 107.10% decrease from 2022.
- Krystal Biotech Inc. annual eps for 2022 was $5.49.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Krystal Biotech Inc. EPS — FAQ
Krystal Biotech Inc. (KRYS) eps over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Krystal Biotech Inc.'s eps?
Krystal Biotech Inc. (KRYS) reported eps of $6.84 for fiscal 2025.
Where can I see KRYS's eps history?
The chart and table above show Krystal Biotech Inc.'s eps by year and by quarter, including the growth rate.